![Mark Pruzanski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Pruzanski
Président chez
INVENTIVA
Fortune : 69 017 $ au 31/05/2026
Profil
Mark E.
Pruzanski was the founder of Apple Tree Venture Management Llc, founded in 1999, serving as Venture Partner from 1999 to 2002.
Dr. Pruzanski was the founder of Intercept Pharmaceuticals, Inc., founded in 2002, serving as Director from 2021 to 2023.
Dr. Pruzanski is the founder of Kirax Corp., founded in 2005.
Current jobs include Chief Executive Officer at Alentis Therapeutics AG starting in 2025, Chairman at Inventiva SA starting in 2024, Director at Biotechnology Innovation Organization, Director at Foundation for the Defense of Democracies, Director at eGenesis, Inc., Independent Director at Equillium, Inc. since 2018, and Director at Intercept Pharma Europe Ltd. since 2015.
Former jobs include Chief Executive Officer at MedicinePlanet, Inc., President & Chief Executive Officer at gIcare Pharma, Inc., Chief Executive Officer at Versanis Bio, Inc. from 2021 to 2023, Director at Evelo Biosciences, Inc., and Entrepreneur-in-Residence at Oak Investment Partners.
Education includes graduate studies at Paul H.
Nitze School of Advanced International Studies (IT), undergraduate degree from McGill University in 1989, doctorate from McMaster University in 1998, and graduate degree from Johns Hopkins University School of Advanced International in 1991.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EQUILLIUM, INC. 0,04 % | 28/05/2026 | 23 799 ( 0,04 % ) | 69 017 $ | 31/05/2026 |
Postes actifs de Mark Pruzanski
| Sociétés | Poste | Début |
|---|---|---|
| EQUILLIUM, INC. | Directeur/Membre du Conseil | 01/09/2018 |
| INVENTIVA | Président | 13/12/2024 |
eGenesis, Inc.
 eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Directeur/Membre du Conseil | - |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and sells pharmaceutical products | Directeur/Membre du Conseil | 19/08/2015 |
Foundation for the Defense of Democracies
 Foundation for the Defense of Democracies Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit research institute that provides national security and foreign policy | Directeur/Membre du Conseil | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Alentis Therapeutics AG
 Alentis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapies to treat cancer and reverse fibrosis | Directeur Général | 15/10/2025 |
Anciens postes connus de Mark Pruzanski
| Sociétés | Poste | Fin |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Fondateur | 08/11/2023 |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur Général | 01/09/2023 |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Mark Pruzanski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Oak Investment Partners
 Oak Investment Partners Investment ManagersFinance Oak Investment Partners invests in companies located in the United States. The firm targets companies operating in the fields of information technology, internet & consumer, financial services, healthcare information & services and clean energy sectors. It participates in early stage capital requirements. | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apple Tree Venture Management Llc//vc
 Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
MedicinePlanet, Inc. | Commercial Services |
Foundation for the Defense of Democracies
Foundation for the Defense of Democracies Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit research institute that provides national security and foreign policy | Commercial Services |
gIcare Pharma, Inc.
 gIcare Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops gastrointestinal drugs | Health Technology |
Paul H. Nitze School of Advanced International Studies (IT)
 Paul H. Nitze School of Advanced International Studies (IT) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
eGenesis, Inc.
eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Health Services |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Alentis Therapeutics AG
Alentis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapies to treat cancer and reverse fibrosis | Health Technology |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and sells pharmaceutical products | Commercial Services |
Johns Hopkins University School of Advanced International
 Johns Hopkins University School of Advanced International Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
